These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8913468)

  • 1. Safety, toleration, and pharmacokinetics of intravenous azithromycin.
    Luke DR; Foulds G; Cohen SF; Levy B
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2577-81. PubMed ID: 8913468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toleration of intravenous azithromycin.
    Luke DR; Foulds G
    Ann Pharmacother; 1997 Sep; 31(9):965-9. PubMed ID: 9296232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously administered azithromycin in pediatric patients.
    Jacobs RF; Maples HD; Aranda JV; Espinoza GM; Knirsch C; Chandra R; Fisher JM; Kearns GL
    Pediatr Infect Dis J; 2005 Jan; 24(1):34-9. PubMed ID: 15665708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
    Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
    Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
    Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
    Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects.
    Cass RT; Brooks CD; Havrilla NA; Tack KJ; Borin MT; Young D; Bruss JB
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5874-80. PubMed ID: 21911572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.
    Merchan LM; Hassan HE; Terrin ML; Waites KB; Kaufman DA; Ambalavanan N; Donohue P; Dulkerian SJ; Schelonka R; Magder LS; Shukla S; Eddington ND; Viscardi RM
    Antimicrob Agents Chemother; 2015 Jan; 59(1):570-8. PubMed ID: 25385115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals.
    Jacks S; Giguère S; Gronwall PR; Brown MP; Merritt KA
    Am J Vet Res; 2001 Dec; 62(12):1870-5. PubMed ID: 11763173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and preliminary safety evaluation of azithromycin in adult horses.
    Leclere M; Magdesian KG; Cole CA; Szabo NJ; Ruby RE; Rhodes DM; Edman J; Vale A; Wilson WD; Tell LA
    J Vet Pharmacol Ther; 2012 Dec; 35(6):541-9. PubMed ID: 22136612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.
    Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A
    Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers.
    Leighton A; Gottlieb AB; Dorr MB; Jabes D; Mosconi G; VanSaders C; Mroszczak EJ; Campbell KC; Kelly E
    Antimicrob Agents Chemother; 2004 Mar; 48(3):940-5. PubMed ID: 14982787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.
    Viscardi RM; Othman AA; Hassan HE; Eddington ND; Abebe E; Terrin ML; Kaufman DA; Waites KB
    Antimicrob Agents Chemother; 2013 May; 57(5):2127-33. PubMed ID: 23439637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of oral azithromycin in humans.
    Luke DR; Foulds G
    Clin Pharmacol Ther; 1997 Jun; 61(6):641-8. PubMed ID: 9209246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
    Purkins L; Wood N; Ghahramani P; Kleinermans D; Layton G; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):30-6. PubMed ID: 14616411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
    Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S; Banfield C; Kantesaria B; Marino M; Clement R; Affrime M; Batra V
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses.
    Del Favero A; Patoia L; Rosina R; Buniva G; Danese A; Bernareggi A; Molini E; Cavenaghi L
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2551-7. PubMed ID: 1839759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.